Melanoma

Disease State Hub

Videos

Research Summaries

Conference Coverage

Patients With Melanoma Using PD-1 Inhibitors Have Increased Risk of Adverse Autoimmune Neurologic Complications

05/31/2024

Jessica Ganga

Patients with melanoma and who are being treated with PD-1 inhibitors have an increased risk of experiencing immune-related neurologic adverse events, compared with patients who are not being treated with...

05/31/2024

Research Summary

Isolated Hepatic Perfusion More Effective Than Standard Treatments For Patients With Isolated Liver Metastases From Uveal Melanoma

05/17/2023

Anthony Calabro, MA

In a multicenter, randomized, open-label, phase 3 trial, researchers set out to determine whether an advanced surgical therapy, isolated hepatic perfusion, could improve outcomes among previously untreated...

05/17/2023

Research Summary

How Does Melanoma Subtype Influence Cutaneous Immune-Related Adverse Events in Patients Who Use ICI Therapy?

03/31/2023

Anthony Calabro, MA

Researchers determined the impact of melanoma subtypes on cutaneous immune-related adverse events and survival among those who received immune checkpoint inhibitor therapy.

03/31/2023

skin cancer

FDA Approves Metastatic, Unresectable Melanoma Treatment

04/21/2022

The US Food and Drug Administration has approved a new medication therapy for the treatment of metastatic and unresectable melanoma.

04/21/2022

Melanoma

Kidney Transplantation Increases Melanoma Risk

07/27/2017

In a recent study, researchers evaluated the association between renal transplantation and risk of melanoma. Also evaluated were other risk factors for developing melanoma in this patient population.

07/27/2017

September 2024

Current Issue

September 2024

Volume 64

Issue 9